Lost in translation: what is stopping inhaled nanomedicines from realizing their potential?
Ther Deliv
.
2014 Jul;5(7):757-61.
doi: 10.4155/tde.14.47.
Authors
Abhinav Kumar
1
,
Lea Ann Dailey
,
Ben Forbes
Affiliation
1
Institute of Pharmaceutical Science, King's College London, 5th Floor, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
PMID:
25287383
DOI:
10.4155/tde.14.47
No abstract available
Keywords:
aerosol medicine; nanoparticle; orally inhaled product; respiratory drug delivery.
MeSH terms
Administration, Inhalation*
Aerosols
Drug Industry
Humans
Nanomedicine*
Nanoparticles
Substances
Aerosols
Grants and funding
NC/C013109/1/NC3RS_/National Centre for the Replacement, Refinement and Reduction of Animals in Research/United Kingdom
NC/C013203/1/NC3RS_/National Centre for the Replacement, Refinement and Reduction of Animals in Research/United Kingdom